【White Paper Introduction】The Chinese skincare market has undergone a remarkable transformation, moving from a position of ’copying homework‘ to one of setting the exam questions. This is particularly evident in the race for peptide-based ingredients, where domestic brands are no longer just following international trends but are actively pioneering new technologies and building significant market share[reference:53]. This white paper analyzes the dynamics of the ’domestic peptide competition‘ in 2026, exploring how Chinese companies are leveraging supply chain advantages, innovative formulations (like the ’single-dose‘ ampoule), and deep consumer insights to compete with and, in some cases, surpass established global giants[reference:54]. The battle for peptide supremacy is a microcosm of the larger shift in the global beauty landscape, where innovation and agility are becoming more valuable than heritage and scale.

【Chapter 1: The PDRN Phenomenon and the ’Single-Dose‘ Victory】The explosive growth of Polydeoxyribonucleotide (PDRN) in the Chinese market is a case study in domestic brand agility. Between 2023 and 2025, e-commerce sales of PDRN products skyrocketed by an astonishing 2700%[reference:55]. Chinese brands, led by players like Dun Meiya which captured a 33.9% market share, achieved this by innovating with the product format: the ’single-dose‘ ampoule[reference:56]. This format, with a CAGR of 13,888%, effectively ’killed‘ the Korean ampoule market by offering a more hygienic, potent, and convenient solution[reference:57]. This was a classic example of a ’dimensionality reduction‘ attack, where domestic brands used superior packaging and delivery technology to outmaneuver foreign competitors. It wasn’t just about the ingredient itself; it was about making it better, cleaner, and easier for the modern consumer to use.

【Chapter 2: The Battle Beyond ’Single-Dose‘ – The Search for a Moat】However, the victory in the ’single-dose‘ battle raises a critical question: is this a sustainable moat, or just a physical barrier that can be easily overcome? As international giants leverage their global supply chains to drive down costs, simply being fast is no longer enough[reference:58]. The next phase of competition is about building a deeper, more defensible advantage. This involves creating proprietary technologies, securing patents for novel peptide sequences, and building a strong brand narrative around scientific innovation. The brands that will ultimately win are those that move beyond just being a supplier of a popular ingredient to becoming a trusted authority on skin regeneration and cellular science. The fight is shifting from who can produce the cheapest single-dose ampoule to who can develop the most effective and scientifically-backed peptide complex.

【Chapter 3: The Consumer Insight Gap and the Path Forward】One of the most significant challenges highlighted by market research is the gap between what brands are promoting and what consumers actually want[reference:59]. While brands are focusing on complex scientific narratives around ’cell regeneration‘ and ’dermal reconstruction,‘ consumers are primarily concerned with practical, immediate results: ’Can it fix my tired skin?‘ and ’Will it make my makeup look less cakey?‘[reference:60] A massive opportunity exists for brands that can bridge this gap[reference:61]. For example, the mention of ’makeup primer‘ as a key use case has quietly risen to 4.2%, yet it is completely ignored by the supply side[reference:62]. This represents a blue ocean of opportunity for brands that can reposition their peptide products from a purely medical-grade treatment to a high-frequency, essential part of a daily beauty routine. The future winners will be those who can marry advanced science with practical, everyday consumer needs.

【Chapter 4: A Unique Industry Conclusion】The domestic peptide competition in 2026 is a story of incredible progress and a warning for the future. Chinese brands have proven they can win on speed, agility, and format innovation. However, the next chapter will be written by those who can build a lasting competitive advantage based on deep science and intellectual property. The key is to move from being a fast follower to a true innovator, creating not just new products, but new categories. The future belongs to brands that can invest in fundamental research, secure their own proprietary ingredients, and communicate their science in a way that resonates with the pragmatic needs of the Chinese consumer. The race is no longer just about who is first to market, but who can build a defensible position in the hearts and minds of consumers as the definitive expert in skin science.